Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Michael Verneris to B-Lymphocytes

This is a "connection" page, showing publications Michael Verneris has written about B-Lymphocytes.

 
Connection Strength
 
 
 
0.166
 
  1. Manes C, Guerrero Moreno M, Cimons J, D'Antonio MA, Brunetti TM, Harbell MG, Selva S, Mizenko C, Borko TL, Lasda EL, Hesselberth JR, Hsieh EW, Verneris MR, Piquet AL, Gapin L, Kedl RM, Klarquist J. B cells shape naive CD8+ T cell programming. J Clin Invest. 2025 Jun 16; 135(12).
    View in: PubMed
    Score: 0.147
  2. Bachanova V, Frankel AE, Cao Q, Lewis D, Grzywacz B, Verneris MR, Ustun C, Lazaryan A, McClune B, Warlick ED, Kantarjian H, Weisdorf DJ, Miller JS, Vallera DA. Phase I study of a bispecific ligand-directed toxin targeting CD22 and CD19 (DT2219) for refractory B-cell malignancies. Clin Cancer Res. 2015 Mar 15; 21(6):1267-72.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)